Matthew Zachary, the keynote speaker for Patient-Centered Oncology Care 2024, recalls what the treatment experience was like when he was diagnosed with a rare pediatric brain cancer in 1996. Zachary is now a patient advocate.
When Matthew Zachary was diagnosed with a rare pediatric brain cancer in 1996, he was many things. A college student. A concert pianist. A self-described “audio nerd” who could not imagine life without enjoying high-fidelity vinyl music.
It was clear to him, as he shuttled between doctors at New York University and Memorial Sloan Kettering Cancer Center, that the experts eyeing his one-of-kind case were focused only on his cancer, and not on the 21-year-old fighting the disease.
Matthew Zachary | Image credit: LinkedIn
Although Zachary remains grateful for the surgery and radiation therapy that saved his life, he still bristles at the fact that no one asked about his treatment goals or his quality of life during a protocol that was brutal at times.
To put it bluntly, he said, “I felt like a piece of meat.”
Zachary will be the keynote speaker at the 2024 meeting of Patient-Centered Oncology Care®, hosted by The American Journal of Managed Care®, where he will address providers, pharmacists, payers, policy experts, and patient advocates in cancer care landscape now vastly different than it was a generation ago. The meeting, taking place September 12-13, 2024, in Nashville, Tennessee, has the theme, “Innovations in Cancer Care: Tales From the Front Lines.” It invites those who involved directly in cancer care to share what they’ve learned, with the expressed goal of making the treatment experience better for patients. (Registration is here.)
Today, concepts of goal setting, shared-decision making and pulling back on regimens that are too harsh are not just wishful thinking—they are built into standards from the National Comprehensive Cancer Network and the American Society of Clinical Oncology. Payment models tie quality of life metrics to reimbursement. And that’s in no small measure because patients like Zachary have spent years speaking out about their experiences and demanding that the health system do better.
Zachary has shared his story with any audience that will listen. He founded the nonprofit Stupid Cancer to offer a platform for young adults with cancer, produced an award-winning documentary and was a podcaster before the term existed. He’s a well-known advocate who has fueled change with humor and a willingness to say what he thinks.
Today, Zachary speaks up for others but is candid that as a 21-year-old, it was his godfather, trained in genetics, who spoke for him and helped him make a crucial decision to forego the recommended course of chemotherapy after he finished radiation. Zachary’s medical team was stunned. They were unaccustomed to being told “no.” But Zachary’s “Uncle Jay,” had researched the chemotherapy side effects and knew the regimen would cause nerve damage in his hands, robbing him of ability to play the piano, along with hearing loss unacceptable to any professional musician.
“In my particular case, biologically, there was no chemotherapy at the time that worked for brain cancer, chemotherapy back then didn't break the blood brain barrier,” Zachary said. “So, it was absolutely unnecessary.”
Zachary said the episode points up a host of problems and inequities in the health care system. He had an advocate with special knowledge of what the drugs of that era could and could not do, but most people did not.
“Who knows these things when you in those moments, when you're terrified?” he asked. “And then who's in charge of telling me? Do they have an agenda or not? And how do I stay protected?”
Zachary can’t imagine his life after cancer if he had not been able to record albums or enjoy music. He knows he is fortunate that he had someone in his corner. Still, he doesn’t hold back when asked to reflect on how his treatment experience would have been different if today’s standards had existed when he was a scared 21-year-old.
“I would have felt more seen. It would have been more humane if they [had] cared about me and not just the biology, if this wasn’t about data or pride of a peer-reviewed paper—arguing over this unique cancer. And I would have had a little more of an objective perspective on what I was actually facing.”
As patients have become better consumers, with access to more information, Zachary believes patients with cancer have a stronger voice in their care. “I’d like to believe that happens more frequently now.”
For more information about Patient-Centered Oncology Care®, visit our registration page.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More